When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GNBT - Generex Bio achieves key milestone in COVID-19 vaccine program
Generex Biotechnology
Generex Biotechnology (OTCQB:GNBT) announces, what it says, is a key milestone in the development of a COVID-19 vaccine, namely, the manufacture of 33 Ii-Key-SARS-CoV-2 peptides using antigenic epitopes (the parts of an antigen that elicit an immune response) predicted by computational algorithms.
More news on: Generex Biotechnology Corporation, Healthcare stocks news,